Dr. Todd Berland was the first vascular surgeon in the world to create a percutaneous arteriovenous fistula

Sep 22, 2017

20 likes | 37 Vues

Dr. Todd Berland was the first vascular surgeon in the world to create a percutaneous arteriovenous fistula for dialysis access using a 4fr system via the radial artery and radial vein. He then went on to present this at LINC in Leipzig, Germany in January of 2017 and just presented the 6 month follow up data on April 7th, 2017 at VAS (Vascular Access Society) in Slovenia where it was awarded "Best Abstract" at that meeting. He will be the National Principal investigator for the study evaluating this device in the US pending final FDA approval.

drtoddberland

Télécharger la présentation

Dr. Todd Berland was the first vascular surgeon in the world to create a percutaneous arteriovenous fistula

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

In August of 2016,Dr. Todd Berland was the first vascular surgeon in the world to create a percutaneousarteriovenous fistula for dialysis access using a 4fr system via the radial artery and radial vein. Dr. Todd Berland
In August of 2016,Dr. Todd Berland was the first vascular surgeon in the world to create a percutaneousarteriovenous fistula for dialysis access using a 4fr system via the radial artery and radial vein. He then went on to present this at LINC in Leipzig, Germany in January of 2017 and just presented the 6 month follow up data on April 7th, 2017 at VAS (Vascular Access Society) in Slovenia where it was awarded "Best Abstract" at that meeting. He will be the National Principal investigator for the study evaluating this device in the US pending final FDA approval.